Angiogenesis in colorectal cancer: therapeutic implications and future directions

被引：7

作者：

Allen, J ^{[1
]}

Bergsland, K ^{[1
]}

机构：

[1] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2004年 / 18卷 / 05期

关键词：

D O I：

10.1016/j.hoc.2004.05.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This article discusses the therapeutic implications and future directions of angiogenesis in colorectal cancer.

引用

页码：1087 / +

页数：34

共 133 条

[1]

André T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO

[2]

2-5

[3]

BASSER R, 2001, P ASCO

[4] Differential expression of transforming growth factors-β1, -β2 and -β3 in human colon carcinoma [J].

Bellone, G ;

Carbone, A ;

Tibaudi, D ;

Mauri, F ;

Ferrero, I ;

Smirne, C ;

Suman, F ;

Rivetti, C ;

Migliaretti, G ;

Camandona, M ;

Palestro, G ;

Emanuelli, G ;

Rodeck, U .

EUROPEAN JOURNAL OF CANCER, 2001, 37 (02) :224-233

[5]

BENSON AB, 2003, P AN M AM SOC CLIN, V22, P243

[6] Tumorigenesis and the angiogenic switch [J].

Bergers, G ;

Benjamin, LE .

NATURE REVIEWS CANCER, 2003, 3 (06) :401-410

[7] Maximizing the potential of bevacizumab in cancer treatment [J].

Bergsland, E ;

Dickler, MN .

ONCOLOGIST, 2004, 9 :36-42

[8]

BILENKER JH, 2003, P ASCO

[9]

BLANKE CD, 2002, P ASCO

[10]

Borgström P, 1999, ANTICANCER RES, V19, P4203

← 1 2 3 4 5 6 7 8 9 10 →